Epstein Secrets

1990 and 1992 and subsequently joined the World Bank where he was involved in the development of the financial sector in Russia. Boris Nlkolk Dr. Boris Nikolic is a Chief Advisor for Science and Technology to Bill Gates at Bill Gates Catalyst 3 (bgc3), Bill Gates Ventures (BGV) and at the Bill & Melinda Gat

Science and Technology to Bill Gates at Bill Gates Catalyst 3 (bgc3), Bill Gates Ventures (BGV) and at the Bill & Melinda Gates Foundation (BMGF). Boris has led investment activities at these Gates-affiliated organizations on both the for-profit and non-for-profit aspects of Bill Gates' activities.

ceived his MD from Zagreb Medical School and his clinical training from the University's Medical Center, University of Zagreb, Croatia. In 1994, Dr. Nikolic joined the Harvard Graduate Program in Immunology. Subsequently, Boris continued to serve in roles of increasing authority including postdoctoral f

n 2012. In December 2012, the Principals invested 530m at a valuation of $311m post money. Other investors included Sergey Brin, Anne Wojciki, NEA, Johnson & Johnson, Roche, Illumina, MPM Capital and Google Ventures. Twist Twist is a synthetic genomics company that is working on a novel oligo and gene synthesis

reign secretary "said it was 'extraordinary' that Boris Johnson chose to 'block the publication of this

ompromise Vaccine Safety. USA Today (7/21, Weise, 10.31M) reports in testimony to a US House subcommittee on Tuesday, "executives from AstraZeneca, Johnson & Johnson, Merck, Moderna and Pfizer said their goal is to have effective vaccines available as soon as possible while following all safety and regulatory gu

reign secretary "said it was 'extraordinary' that Boris Johnson chose to 'block the publication of this i

s-may- ready-early-2021/5478232002/> (7/21, Weise, 10.31M) reports in testimony to a US House subcommittee on Tuesday, "executives from AstraZeneca, Johnson & Johnson, Merck, Modema and Pfizer said their goal is to have effective vaccines available as soon as possible while following all safety and regulatory guid

2/22, Booth, Adam, 10.52M) reports Prime Minister Boris Johnson on Monday "outlined detailed plans in Pa

ication, 8.41M) also have reports. J&J Says It Should Have Enough Doses For More Than 20M By End Of March. The Hill (2/22, Sullivan, 5.69M) reports Johnson & Johnson said Monday that it "plans to have enough doses of its vaccine for more than 20 million Americans by the end of March" if its vaccine is authorized

says, "laid bare the missteps in Prime Minister Boris Johnson's handling of the pandemic." Italian PM'

uccia, Subscription Publication, 8.41M), Politico (1/26, Cancryn, Roubein, 6.73M), and The Hill (1/26, Sullivan, Samuels, 5.69M) also have reports. Johnson & Johnson Expects To Report Vaccine Data Next Week. Reuters (1/26, Mishra, O'Donnell) reports that on Tuesday, Johnson & Johnson "said it expected to report

reign secretary "said it was 'extraordinary' that Boris Johnson chose to 'block the publication of this

ompromise Vaccine Safety. USA Today (7/21, Weise, 10.31M) reports in testimony to a US House subcommittee on Tuesday, "executives from AstraZeneca, Johnson & Johnson, Merck, Moderna and Pfizer said their goal is to have effective vaccines available as soon as possible while following all safety and regulatory gu

reign secretary "said it was `extraordinary' that Boris Johnson chose to block the publication of this i

ompromise Vaccine Safety. USA Today (7/21, Weise, 10.31M) reports in testimony to a US House subcommittee on Tuesday, "executives from AstraZeneca, Johnson & Johnson, Merck, Moderna and Pfizer said their goal is to have effective vaccines available as soon as possible while following all safety and regulatory gu

ally did meet him, because I knew 47 (Pages 182 to 185) 47 (Pages 182 to 185) Page 182 1 his -- I don't know if he was chief of staff or 2 whoever, Boris. And I met him, I think, once. I may 3 have met him actually at 71st Street. I may have 4 once. I don't remember if I met him there or at a 5 res

GHISLAINE MAXWELL: Do you want the names? 10 TODD BLANCHE: Sure. Go ahead. 11 GHISLAINE MAXWELL: Elizabeth Johnson -- 12 Johnson & Johnson. 13 TODD BLANCHE: When did -- as far as you 14 know, when did the relationship between Ms. Johnson 15 and Mr. Epstein start? 16